Medication info
Telmisartan Tablet 40 mg (Telmisartan)

Telmisartan Tablet 40 mg (Telmisartan)

Prescription medicationOrally disintegrating TabletOral
Ingredient · strength
Telmisartan›Strength being verified
Manufacturer / importer
(Co., Ltd.) BC World Pharmaceutical
Appearance
White round orodispersible tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202502552 · Approved 2025.09.26 · Insurance code 653103880

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve; take without water. Do not crush or divide this medicine. 1. Essential hypertension Adults: Administer telmisartan 40 mg orally once daily, with or without food. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4~8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg orally once daily, with or without food. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment; the dose must not exceed 40 mg once daily.

Ingredients

Manufacturer
(Co., Ltd.) BC World Pharmaceutical

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease (myocardial infarction, stroke, etc.)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • evidence of end-organ damage in high-risk diabetes
View approved original text

This medicine is primarily used to treat essential hypertension. It also helps reduce the risk of cardiovascular disease in patients with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack, or in high-risk diabetes patients. It is particularly effective in patients over 55 who have difficulty using ACE inhibitors, reducing the risk of mortality due to myocardial infarction, stroke, and cardiovascular diseases, thereby improving health.

How to take

Adult dose

This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve; take without water. Do not crush or divide this medicine. 1. Essential hypertension Adults: Administer telmisartan 40 mg orally once daily, with or without food. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4~8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg orally once daily, with or without food. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment; the dose must not exceed 40 mg once daily.

Precautions

This medication may cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, pregnant or breastfeeding women, individuals with severe liver impairment, and patients with hereditary angioedema should not take this medication. Elderly patients, those with hyperkalemia, patients with liver disease, heart disease, or kidney disease should take this medication with caution and should regularly monitor blood pressure, kidney function, and electrolyte status. If symptoms such as excessive lowering of blood pressure, dizziness, fainting, difficulty breathing, or swelling of the face or lips occur while taking this medication, medical consultation should be sought immediately. Patients with impaired kidney function or those undergoing hemodialysis should periodically check their blood potassium and creatinine levels when taking this drug. This medication has an increased risk of side effects when taken with other antihypertensives, especially ACE inhibitors, aliskiren, and potassium-sparing diuretics, hence caution is necessary during concurrent use. Patients undergoing surgery should ideally discontinue this medication 24 hours before surgery. Caution should be exercised as dizziness or fainting may occur while driving or operating machinery. This medication contains sorbitol, so patients with fructose intolerance should avoid it. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, and immediate medical evaluation should be sought. Safety and effectiveness of this drug have not been established in children; it is advised to keep it out of reach of children and to avoid moisture and direct sunlight during storage.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 85 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbance
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormality
  • liver impairment
  • increased sweating
  • pruritus
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • hives
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • renal impairment
  • chest pain
  • asthenia
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • facial spasm
  • sensory disturbance
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • vertigo
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • arrhythmia
  • shock
  • loss of consciousness
  • jaundice
  • anaphylactoid symptoms
  • interstitial pneumonia
  • rhabdomyolysis
  • angioedema
  • gastrointestinal bleeding

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius room temperature. This helps to preserve the effectiveness of the drug for a long time.

Appearance and packaging

Appearance

White round orodispersible tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.